Dow Up 0.11% Nasdaq Up 0.50%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
6.98 Down 0.05(0.71%) Aug 29, 4:00PM EDT
|After Hours : 6.98 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Prev Close:7.03
Open:7.03
Bid:6.93 x 300
Ask:N/A
1y Target Est:13.20
Beta:1.43
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:6.83 - 7.04
52wk Range:2.05 - 8.25
Volume:942,882
Avg Vol (3m):1,550,890
Market Cap:730.02M
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MACK

Comparison

Symbol% ChgMkt Cap
MACKDown 0.71%730.02M
IMMUUp 4.06%310.07M
LRUSF 0.00%57.96M
THLDUp 1.96%246.96M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.97
Quarterly EPS Est (Sep-14) :-0.26
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-1.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback